60 Participants Needed

Advanced MRI Techniques for Epilepsy

EA
JJ
Overseen ByJustin J Jeong, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Wayne State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 6 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new MRI technique to aid in planning surgeries for children with drug-resistant focal epilepsy. The goal is to use advanced imaging to better map the brain before surgery, reducing risks and increasing the chances of stopping seizures. Participants include children and teens with epilepsy unresponsive to medication and scheduled for a specific type of surgery. The trial employs brain scans and cognitive assessments to evaluate the effectiveness of this new approach. Importantly, the results will not influence any immediate medical decisions until proven effective. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could improve surgical outcomes for future patients.

Will I have to stop taking my current medications?

The trial does not specify whether participants need to stop taking their current medications. It focuses on advanced MRI techniques and does not mention any medication changes.

What prior data suggests that this MRI technique is safe for pediatric epilepsy surgery?

Research has shown that MRI (magnetic resonance imaging) provides a safe and comfortable way to study epilepsy in children. For instance, studies have found that advanced MRI machines, such as the 7T MRI, are well-tolerated by children with epilepsy. This method effectively identifies brain issues without causing significant discomfort or harm. Importantly, these MRI procedures do not require contrast agents or sedation, further reducing the risk of side effects.

In summary, MRI is a non-invasive imaging method with a strong safety record, making it a reliable tool for research and clinical use, especially in children with epilepsy.12345

Why are researchers excited about this trial?

Researchers are excited about using advanced MRI techniques for epilepsy because these methods offer a new way to understand what's happening in the brain of patients with drug-resistant epilepsy. Unlike traditional treatments, which often focus on managing symptoms with medications like anti-seizure drugs, this approach provides detailed images and insights into brain structure and function before and after surgery. This could help tailor surgical interventions more precisely, potentially leading to better outcomes for patients who haven't found relief through drugs alone. By capturing changes over time, these MRI techniques might reveal how epilepsy affects the brain, paving the way for more personalized and effective treatment strategies.

What evidence suggests that this advanced MRI technique is effective for epilepsy?

Research has shown that advanced MRI techniques play a crucial role in treating epilepsy, especially when medications fail. In this trial, participants with drug-resistant epilepsy will undergo two longitudinal brain MRI evaluations. Imaging studies have found that MRI can detect changes in the brains of those with drug-resistant epilepsy. By enhancing MRI sensitivity, doctors can plan surgeries more effectively, leading to improved outcomes. For instance, one study found that patients whose initial MRI showed no issues could still benefit from surgery with enhanced imaging techniques. Overall, advanced MRI methods offer hope for better surgery planning and outcomes in epilepsy treatment.678910

Are You a Good Fit for This Trial?

This trial is for children and adolescents aged 3-19 with drug-resistant focal epilepsy who are planning to undergo a specific two-stage surgery, as well as healthy controls aged 5-19. Participants must not have claustrophobia, pervasive developmental or psychiatric conditions predating seizures, significant brain malformations, history of prematurity or hypoxic-ischemic events, hemiplegia, dysmorphic syndromes, or excessive head motion during MRI.

Inclusion Criteria

I am between 3-19 years old with epilepsy not improved by medication, planning a specific surgery.
I am aged 5-19, healthy, with no cognitive or motor issues, and a normal brain MRI.

Exclusion Criteria

Hemiplegia on preoperative neurological examination by pediatric neurologists
History of claustrophobia
MRI abnormalities showing massive brain malformation and other extensive lesions affecting spatial normalization accuracy and parcellation accuracy
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Preoperative Evaluation

Participants undergo advanced brain MRI and neurocognitive evaluation to assess preoperative conditions

1 month
1 visit (in-person)

Surgery and Immediate Postoperative Assessment

Participants undergo epilepsy surgery and immediate postoperative assessment using DCNN tract classification

During procedure

Follow-up

Participants are monitored for safety and effectiveness, including neurocognitive outcomes, after surgery

1.5 years
Multiple visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Brain Magnetic Resonance Imaging
Trial Overview The study is testing a new diffusion-weighted MRI technique that aims to improve surgical outcomes in pediatric epilepsy by better identifying critical brain pathways. It uses advanced imaging and neurocognitive tests without the need for contrast agents or sedation. The goal is to reduce postoperative deficits while increasing the chance of seizure freedom.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Patients with drug-resistant epilepsyExperimental Treatment2 Interventions

Brain Magnetic Resonance Imaging is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:

🇪🇺
Approved in European Union as MRI for:
🇺🇸
Approved in United States as MRI for:
🇨🇦
Approved in Canada as MRI for:
🇯🇵
Approved in Japan as MRI for:
🇨🇳
Approved in China as MRI for:
🇨🇭
Approved in Switzerland as MRI for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wayne State University

Lead Sponsor

Trials
318
Recruited
111,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Published Research Related to This Trial

New advancements in magnetic resonance imaging (MRI) techniques are enhancing the ability to investigate and understand epilepsy in patients, making MRI a more valuable tool in clinical settings.
Techniques like magnetic resonance spectroscopy and functional MRI are not only providing critical clinical information but also uncovering fundamental insights into the mechanisms of epilepsy.
Magnetic resonance and functional magnetic resonance imaging: tools for the study of human epilepsy.Kuzniecky, R.[2019]
A new epilepsy-specific MRI protocol was developed based on a study of 2,740 patients, which includes essential sequences like FLAIR and T(2)-weighted images to reliably detect small epileptogenic lesions.
This protocol, featuring specific slice thickness and orientations, aims to improve early identification of patients who may benefit from epilepsy surgery, making it practical for use outside specialized centers.
Proposal for a magnetic resonance imaging protocol for the detection of epileptogenic lesions at early outpatient stages.Wellmer, J., Quesada, CM., Rothe, L., et al.[2022]
MRI is the preferred neuroimaging technique for evaluating patients with epilepsy due to its ability to provide detailed structural information.
Functional imaging techniques, such as MR spectroscopy and PET, enhance the understanding of the epileptic substrate and its functional status, suggesting that MRI-based methods could become more central in cost-effective patient evaluations.
Neuroimaging in epilepsy.Sitoh, YY., Tien, RD.[2019]

Citations

Evaluation of Magnetic Resonance (MR) Findings in ...This study aims to evaluate the outcome of magnetic resonance imaging in determining the etiology in patients with refractory epilepsy and to reveal pathologies ...
Structural and functional alterations in MRI-negative drug- ...In this study, we assessed structural and functional brain alterations in patients with DRE and drug-sensitive epilepsy (DSE) by analyzing whole ...
Imaging blood–brain barrier dysfunction in drug‐resistant ...We scanned 50 drug-resistant epilepsy (DRE) patients and 58 control participants from four global specialized epilepsy centers using DCE-MRI.
Characteristics and Surgical Outcomes of Patients With ...Conclusions Patients with epilepsy who are MRI− can be successfully treated with surgery. Improved sensitivity of MRI will improve the outcomes of presurgically ...
Functional and effective connectivity analysis of drug ...We propose using resting-state functional magnetic resonance imaging (rs-fMRI) data to characterize connectivity patterns in drug-resistant epilepsy.
A review of neuroimaging in epilepsy: Diagnostic strategies ...Navigating neural landscapes: a comprehensive review of magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) applications in epilepsy.
Study Details | NCT02531880 | Investigation of Blood-Brain ...The primary outcomes are (1) description of the safety profile of mangafodipir administration in patients with epilepsy, and (2) evaluation of the utility of ...
Magnetic resonance imaging scan to detectrelevant ... - NCBIThe aim of this review is to assess how well MRI performns in detecting brain lesions or other relevant abnormalities in people with epilepsy.
Accuracy, Effectiveness, and Safety of Robot-Assisted ...Robot-assisted LITT offers high precision, positive seizure outcomes, and minimal complications, comparable to nonrobotic methods, and is suitable for treating ...
Ultra-High Field 7T MRI in a Drug-Resistant Pediatric ...7T MRI in children with epilepsy is well tolerated and associated with a 23% improvement in lesion detection, directly affecting clinical management and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security